Pharmaceutical companies skyrocket the price of prescriptions to Medicare because taxpayers are paying for it
“That means of the $141 million they spent on this drug in 2022, $133 million of it was wasted”
News on the Net -- Wall Street Apes, Bio and Archives--March 21, 2025
News in Brief—News Headlines | Comments | Reader Friendly | Subscribe | Email Us
This is the worst one yet. Pharmaceutical companies skyrocket the price of prescriptions to Medicare because taxpayers are paying for it
— Wall Street Apes (@WallStreetApes)March 21, 2025
- Drug Tetrabenazine, Medicare pays $2,600 per prescription
- Regular price $75
- Medicare is paying 34X THE PRICE PER PRESCRIPTION
-… pic.twitter.com/vRd3cwmBcB
View Comments
News on the Net——Bio and Archives
News from around the world